Are Global Health Ltd latest results good or bad?

Feb 04 2026 07:24 PM IST
share
Share Via
Global Health Ltd's latest results show mixed performance: while net profit slightly declined by 0.36% from the previous quarter, revenue grew by 6.63%, marking the seventh consecutive quarter of growth. However, operating margins contracted due to rising costs, and the company's high valuation has raised some investor concerns.
Global Health Ltd's latest financial results for the quarter ended September 2025 reflect a mixed operational performance. The company reported a net profit of ₹158.44 crores, which represents a slight decline of 0.36% compared to the previous quarter, contrasting with a significant year-on-year growth of 21.09%. Revenue for the quarter reached ₹1,099.22 crores, marking a sequential increase of 6.63% and a year-on-year growth of 14.91%. This growth indicates the company's ability to maintain a positive revenue trajectory, achieving its seventh consecutive quarter of sequential revenue growth.
However, the operating margin, which stood at 22.46%, experienced a contraction of 146 basis points from the prior quarter, primarily attributed to rising employee costs that outpaced revenue growth. Despite this margin compression, the operating profit before depreciation, interest, and tax (excluding other income) remained robust, reflecting the company's operational resilience. The company's return on equity (ROE) was reported at 15.90%, showcasing strong capital efficiency, while the return on capital employed (ROCE) further reinforced its operational excellence at 22.53%. These metrics highlight the company's capability to generate substantial returns on shareholder investment. In terms of valuation, Global Health is currently trading at a premium, with a price-to-earnings ratio of 59 times trailing twelve-month earnings, which has led to some investor skepticism regarding its valuation relative to the broader hospital sector. The company's financial position remains strong, characterized by a negative net debt, indicating it holds more cash than total debt, which provides significant financial flexibility. Overall, while Global Health Ltd demonstrates strong operational fundamentals and revenue growth, it faces challenges related to margin pressures and elevated valuation metrics. The company saw an adjustment in its evaluation, reflecting the complexities of its current financial landscape.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News